TYRA BIOSCIENCES INC (TYRA:NASDAQ)
$19.94 -0.03 (-0.1502%)
Analysed TYRA BIOSCIENCES INC (TYRA:NASDAQ) News Sources
Tyra Biosciences' Weak Investor Sentiment Reflects Macro Pressures, Renewed SURF-302 Concerns, BofA Says
10-06-2026
yahoo.com
Is Tyra Biosciences (TYRA) Too Reliant On Dabogratinib Amid Renewed SURF-302 Skepticism?
12-06-2026
yahoo.com
TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout
04-09-2026
stocktwits.com
Tyra Biosciences to Present at the Cantor Global Healthcare Conference
08-09-2026
yahoo.com
Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
09-09-2026
yahoo.com
Tyra Biosciences shares plunge 30% after Phase 2 dabogratinib data
09-09-2026
advfn.com
Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress
09-09-2026
yahoo.com
Tyra disappoints investors with bladder cancer data
09-09-2026
biopharmadive.com
Tyra Plummets To 10-Month Low On Mixed Cancer Test; Why Analysts Are Upbeat
09-09-2026
yahoo.com
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
14-09-2026
yahoo.com
What is the current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ) is $19.94.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is $-0.03.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is -0.1502%.
What is the most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is .
SEC-8K** Filing Available For TYRA BIOSCIENCES INC (TYRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.